IVI and Gabon
Dengue Vaccine Initiative (DVI)
From 2014 to 2017, IVI expanded its dengue research operations into Africa. The studies began with the establishment of a new field site in Gabon. DVI, which succeeded the Pediatric Dengue Vaccine Initiative (PDVI), was an IVI-led initiative that carried on PDVI’s efforts to build the basis for dengue vaccine selection and vaccination implementation in endemic countries.
In Gabon, DVI conducted field studies in Lambaréné, including disease surveillance and data capturing operations to determine the cost of illness on the health system. The results of the DVI study in Gabon contributed to the development of the dengue vaccines and strengthened the surveillance capacity of diseases researchers in Gabon.